K

Kyowa Kirin

Global specialty pharma focused on antibodies

Director – Manufacturing Project and Product Management

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeMarlow, UKNo salary listedIn-person

About the Job

Requirements

  • Significant experience in the biopharmaceutical industry, including prior experience as a technical or functional team lead in drug substance, drug product, formulation, analytical, or related functions.
  • Experience in project and program management across chemistry, manufacturing, and controls (CMC) and partner functions.
  • Experience with pharmaceutical drug substance and drug product manufacturing and analytical development, validation, scale-up, technology transfer, and global regulatory requirements.
  • Experience preparing and negotiating pharmaceutical development or commercial agreements.
  • Experience with global change controls.
  • Experience with multiple dosage forms, including sterile injectables, pre-filled syringes, auto-injectors, gene and cell therapies, tablets, capsules, and syrups, and with related manufacturing processes.
  • Experience overseeing supply chain processes for biologics, small molecules, secondary packaging, and cold-chain products.
  • Experience working effectively with contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), vendors, and suppliers, including building and maintaining successful partnerships.

Responsibilities

  • Lead cross-functional and cross-regional CMC project teams, ensuring effective planning, coordination, and execution of CMC strategies across all product lifecycle stages.
  • Establish, approve, and govern integrated CMC development strategies, action plans, and timelines for projects and products under the P&PM team’s responsibility.
  • Oversee timely execution and delivery of CMC and related functional milestones across multiple projects and products, ensuring consistency, quality, and prioritisation at the portfolio level.
  • Provide strategic leadership and guidance on CMC development direction, enabling global teams to adapt plans proactively in response to scientific, technical, regulatory, or business changes.
  • Monitor portfolio-level progress of CMC strategies and execution to ensure optimal outcomes, value maximisation, and efficient resource utilisation across projects and products.
  • Drive cross-functional and cross-regional collaboration to resolve complex issues, align stakeholders, and support integrated, timely, and well-governed decision-making.
  • Oversee proactive identification, assessment, and management of CMC-related risks at project and portfolio levels, ensuring robust mitigation strategies and appropriate escalation to governance bodies.
  • Oversee development and presentation of multiple strategic options to top management, clearly articulating cost, speed, risk, and value impacts to support informed decision-making.
  • Oversee budget strategy, planning, submission, allocation, and expense monitoring across the portfolio.
  • Strengthen CMC governance and initiatives by defining and implementing organisational strategies related to operating model design, operational expenditure optimisation, and departmental policies.
  • Develop and support CMC Leads and P&PM team members to strengthen their ability to define, develop, and execute effective CMC strategies while fostering future leadership capabilities.

Desired Qualifications

  • Experience leading global cross-functional teams.
  • Experience with North America, European Union, Japan, and global regulatory filings and submissions.

About the Company

Kyowa Kirin

Global specialty pharma focused on antibodies

1) What does this company do? Kyowa Kirin develops specialty pharmaceutical drugs with a focus on nephrology, oncology, and immunology, built on a foundation of fermentation technology and antibody science. 2) How does this company's product(s) work? It uses fermentation-derived biology and antibody-based approaches to create therapies that target kidney disease, cancer, and immune-related conditions, delivered as approved medicines after research, development, and clinical testing. 3) How is this company different from its competitors? It blends deep fermentation and microbiology expertise with antibody technology from its history, plus a global specialty-drug focus, resulting from a merger of Kyowa Hakko Kogyo and Kirin Pharma that combined fermentation know-how with pharmaceutical resources. 4) What is this company's goal? To develop and commercialize innovative treatments that address unmet medical needs in nephrology, oncology, and immunology on a global scale.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Tokyo, Japan
Founded
1885

Recently Posted Jobs

Explore more opportunities at Kyowa Kirin

See more jobs